Authors:
Poll, LW
Dahl, SV
Koch, JA
Borner, D
Willers, R
Cohnen, M
Jung, G
Scherer, A
Niederau, C
Haussinger, D
Modder, U
Citation: Lw. Poll et al., Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement., ROFO-F RONT, 173(10), 2001, pp. 931-937
Citation: C. Niederau, Diagnosis and treatment of chronic hepatitis C: Practical recommendations and new developments, MED KLIN, 96(10), 2001, pp. 599-607
Authors:
Niederau, C
Rolfs, A
vom Dahl, S
Haussinger, D
Poll, LW
Mengel, E
Beck, M
Citation: C. Niederau et al., Diagnosis and therapy of Gaucher's disease: Current recommendations of theGerman treatment centers in the year 2000, MED KLIN, 96(1), 2001, pp. 32-39
Authors:
Poll, LW
Koch, JA
vom Dahl, S
Willers, R
Scherer, A
Boerner, D
Niederau, C
Haussinger, D
Modder, U
Citation: Lw. Poll et al., Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results, SKELETAL RA, 30(9), 2001, pp. 496-503
Authors:
Heintges, T
Petry, W
Kaldewey, M
Erhardt, A
Wend, UC
Gerlich, WH
Niederau, C
Haussinger, D
Citation: T. Heintges et al., Combination therapy of active HBsAg vaccination and interferon-alpha in interferon-alpha nonresponders with chronic hepatitis B, DIG DIS SCI, 46(4), 2001, pp. 901-906
Authors:
Schulz, HU
Hoenl, H
Schrader, T
Kropf, S
Halangk, W
Ochmann, C
Matthias, R
Letko, G
Roessner, A
Lippert, H
Niederau, C
Citation: Hu. Schulz et al., Randomized, placebo-controlled trial of lazaroid effects on severe acute pancreatitis in rats, CRIT CARE M, 29(4), 2001, pp. 861-869
Authors:
Poll, LW
Koch, JA
vom Dahl, S
Loxtermann, E
Sarbia, M
Niederau, C
Haussinger, D
Modder, U
Citation: Lw. Poll et al., Extraosseous manifestation of Gaucher's disease type I: MR and histological appearance, EUR RADIOL, 10(10), 2000, pp. 1660-1663
Authors:
Han, B
Klonowski-Stumpe, H
Luthen, R
Schreiber, R
Haussinger, D
Niederau, C
Citation: B. Han et al., Menadione-induced oxidative stress inhibits cholecystokinin-stimulated secretion of pancreatic acini by cell dehydration, PANCREAS, 21(2), 2000, pp. 191-202
Authors:
Erhardt, A
Reineke, U
Blondin, D
Gerlich, WH
Adams, O
Heintges, T
Niederau, C
Haussinger, D
Citation: A. Erhardt et al., Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B, HEPATOLOGY, 31(3), 2000, pp. 716-725
Citation: G. Strohmeyer et C. Niederau, Diabetes mellitus and hemochromatosis, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, 2000, pp. 268-277
Citation: C. Niederau et G. Strohmeyer, Survival in hemochromatosis, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, 2000, pp. 359-368
Authors:
Sata, N
Klonowski-Stumpe, H
Han, B
Luthen, R
Haussinger, D
Niederau, C
Citation: N. Sata et al., Supraphysiologic concentrations of cerulein induce apoptosis in the rat pancreatic acinar cell line AR4-2J, PANCREAS, 19(1), 1999, pp. 76-82
Citation: C. Niederau et E. Gopfert, The effect of extracts from Schollkraut and Curcuma on upper abdominal pain due to dysfunction of the biliary system: Results of a placebo-controlled, double-blind study, MED KLIN, 94(8), 1999, pp. 425-430
Authors:
Becker, K
Berger, M
Niederau, C
Frieling, T
Citation: K. Becker et al., Individual fecal a(1)-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis, HEP-GASTRO, 46(28), 1999, pp. 2309-2314
Citation: K. Becker et al., Fecal excretion of alpha(2)-macroglobulin: A novel marker for disease activity in patients with inflammatory bowel disease, Z GASTROENT, 37(7), 1999, pp. 597-605
Citation: C. Niederau et Jh. Grendell, Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists, DIGESTION, 60, 1999, pp. 69-74